Vascular complications of selected cancer therapies-Reference-Cited by-同舟云学术

Vascular complications of selected cancer therapies

Published:2008-10-14 Issue:12 Volume:5 Page:797-805
ISSN:1743-4297
Container-title:Nature Clinical Practice Cardiovascular Medicine
language:en
Short-container-title:Nat Rev Cardiol

Author:

Daher Iyad N,Yeh Edward TH

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.nature.com/articles/ncpcardio1375.pdf

Reference70 articles.

1. Hewitt ME et al. (2006) From Cancer Patient To Cancer Survivor: Lost In Transition. Washington, DC: The National Academies Press

2. Death rates by age, sex, race, and underlying cause: United States, 1981–2004 (NMR04a). [ http://205.207.175.93/aging/TableViewer/tableView.aspx?ReportId=424 ]

3. Yeh ET et al. (2004) Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management. Circulation 109: 3122–3131

4. Yeh ET (2006) Cardiotoxicity induced by chemotherapy and antibody therapy. Annu Rev Med 57: 485–498

5. van den Belt-Dusebout AW et al. (2006) Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 24: 467–475

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer drugs and cardiotoxicity: the role of cardiomyocyte and non-cardiomyocyte cells;Frontiers in Cardiovascular Medicine;2024-07-11

2. An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management;Clinical and Experimental Nephrology;2024-04-27

3. Effects of 5-fluorouracil co-administration on blood pressure in patients maintained on antihypertensives: a retrospective case series;PHARMAZIE;2023

4. Call for Formalized Pathways in Vascular Medicine Training;Journal of the American College of Cardiology;2022-05

5. Far‐infrared radiation alleviates cisplatin‐induced vascular damage and impaired circulation via activation of HIF‐1α;Cancer Science;2022-04-20